Anette Thygesen-Kjaerbye

Copenhagen, DK 
Copenhagen, DK 

Overview

Anette Thygesen-Kjaerbye practices practicing medicine in Copenhagen, Denmark.

Her clinical expertise encompasses Postpartum Depression, Neonatal Abstinence Syndrome, Streptococcal Group B Infection, and Asymptomatic Bacteriuria.

She is actively involved in clinical research, co-authoring 20 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Copenhagen, Denmark
Other Locations
Hvidovre, Denmark
Hillerod, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicentre, Multinational, Parallel Group, Observer-blind, Randomised, Placebo-controlled Study on the Group B Streptococcus Vaccine (GBS-NN/NN2), Investigating the Immunogenicity and Safety of Four Vaccination Regimens in Pregnant Woman, Assessing IgG Specific to AlpN Proteins in Cord Blood and Maternal Blood, and the Safety Profile in Mother and Infant up to 6 Months Post-delivery
A Multicentre, Multinational, Parallel Group, Observer-blind, Randomised, Placebo-controlled Study on the Group B Streptococcus Vaccine (GBS-NN/NN2), Investigating the Immunogenicity and Safety of Four Vaccination Regimens in Pregnant Woman, Assessing IgG Specific to AlpN Proteins in Cord Blood and Maternal Blood, and the Safety Profile in Mother and Infant up to 6 Months Post-delivery
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Biological
Study Phase: Phase 2

20 Total Publications

Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study.
Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study.
Journal: The Lancet. Infectious diseases
Published: August 12, 2025

Frequently Asked Questions about Anette Thygesen-Kjaerbye

Is Anette Thygesen-Kjaerbye a top-rated expert for Postpartum Depression?

MediFind is an objective health platform that identifies experts based on real-world data. Anette Thygesen-Kjaerbye is classified as an Experienced expert for Postpartum Depression, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anette Thygesen-Kjaerbye participate in research or clinical trials?

Yes. Anette Thygesen-Kjaerbye has published 20 articles and abstracts on conditions like Postpartum Depression. You can view a list of Anette Thygesen-Kjaerbye's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Thygesen-Kjaerbye's expertise for a condition
ConditionClose
        View All 9 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile